Evidence map›Paper›PMID 35791408›Full record

ArticleOpen access rheumatology : research and reviews2022

From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia.

Mishal F Karremah, Rola Y Hassan, Ammar Z Faloudah, Lujain K Alharbi, Albraa F Shodari, Ahmad A Rahbeeni, Nouf K Alharazi, Ahmad Z Binjabi, Mohamed M Cheikh, Hanadi Manasfi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Open access rheumatology : research and reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Mishal F KarremahDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.ORCID 0000-0002-5457-0207
Rola Y HassanDepartment of Medicine, Division of Rheumatology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.ORCID 0000-0002-3878-5187
Ammar Z FaloudahDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Lujain K AlharbiDepartment of Medicine, Division of Rheumatology, King Fahad Hospital, Madinah, Saudi Arabia.
Albraa F ShodariDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Ahmad A RahbeeniDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Nouf K AlharaziDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Ahmad Z BinjabiDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Mohamed M CheikhAlzaidi Chair of Research in Rheumatic Diseases, Umm Alqura University, Makkah, Saudi Arabia.ORCID 0000-0002-1040-0126
Hanadi ManasfiDepartment of Medicine, Specialized Medical Center, Riyadh, Saudi Arabia.
Sultana AbdulazizDepartment of Medicine, King Fahad General Hospital, Jeddah, Saudi Arabia.ORCID 0000-0002-4381-8983
Albadr Hamza HusseinDepartment of Medicine, Division of Rheumatology, King Fahad Hospital, Madinah, Saudi Arabia.
Ahmed AlhazmiDepartment of Medicine, Division of Rheumatology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Hani AlmoallimDepartment of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.ORCID 0000-0003-2582-8317
Umm al-Qura University · SAKing Fahad Hospital Jeddah · SAKing Fahd Armed Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Early diagnosis and treatment is associated with improved outcomes in patients with systemic lupus erythematosus (SLE). Studying the journey of SLE patients in Saudi Arabia is essential to direct future health-care plans. Patients and Methods: This is a cross-sectional, multicenter study. Eligibility criteria included a diagnosis of SLE that was confirmed by a rheumatologist. Patients younger than 18 at the time of interview were excluded. Primary objectives were to determine time from first symptoms to initial physician visit (Lag 1), time from initial physician visit to encounter with rheumatologist (Lag 2), time from first visit to a rheumatologist to diagnosis of SLE (Lag 3), and time from diagnosis to start of treatment (Lag 4). Secondary objectives were to determine the number and specialty of physicians seen by patients, the speciality type that confirmed the diagnosis, first symptoms experienced, and age at first diagnosis of SLE. Results: Three hundred patients (92.3% women) with SLE were evaluated. Mean age at diagnosis was 29.92 years. Mean disease duration was 8.1 years. The majority were college educated (43.0%). The most common initial symptom was joint pain (68%), followed by skin rash (23%), and fever (3.7%). Lag 1 was less than one month in 68.2% of patients. Lag 2 was less than one month in 33.4% of patients and exceeded one year in 25.8%. Lag 3 was less than 1 month in 68.7% of patients. Lag 4 was less than one month in 94.4% of patients. The diagnosis of SLE was made most frequently by rheumatologists (80%). Evaluation by primary care, orthopedic and dermatology physicians were associated with delays in diagnosis. Conclusion: Delay was marked in Lag 2. Causes of delay included evaluation by non-specialists and visiting higher numbers of physicians before diagnosis confirmation.

Indexed as

delayphysicianrheumatologySaudi Arabiasystemic lupus erythematosus

Identifiers

PMID35791408
PMCPMC9250784
OpenAlexW4283712520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.